BMC cancer · 2025
De Novo bone metastasis in breast cancer: tumor biology and survival outcomes in a retrospective study from Pakistan.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Anwar Eman, Amjad Aqsa, Zubairi Akbar Jaleel, Ali Muhammad Maisam, Zeeshan Sana
Аннотация
PURPOSE: Breast cancer is the leading cause of cancer-related deaths among women, with 20-30% of early-stage patients eventually developing metastases, often in bones. Despite the high incidence, risk factors for de novo bone metastasis are understudied in local populations.
METHODS: This single-center, retrospective study was conducted at Aga Khan University Hospital, Karachi. Patient demographics, tumor characteristics, and risk factors were assessed. Patients with de novo bone metastasis were compared to non-stage IV cases using binary univariate and multivariate logistic regression, with significance set at p < 0.05.
RESULTS: Among 2565 patients, 93 (3.6%) presented with bone only metastasis (BOM) and 135 (5.3%) presented with bone and visceral metastasis together. The median age was 51 years, with females predominating. Multivariate analysis revealed that triple-negative breast carcinoma had lower odds (OR 0.36, 95% CI (0.16-0.79) p < 0.001). Advanced T and N stages and tumor grade II were linked to higher odds of bone-only metastasis. The 2-year overall survival of participants with BOM was 93% (CI: 83.7-97%).
CONCLUSION: This study identifies key risk factors that provide the basis for early detection and intervention strategies. While it has a few limitations, these findings can guide future research and inform risk assessment models for more diverse populations.
METHODS: This single-center, retrospective study was conducted at Aga Khan University Hospital, Karachi. Patient demographics, tumor characteristics, and risk factors were assessed. Patients with de novo bone metastasis were compared to non-stage IV cases using binary univariate and multivariate logistic regression, with significance set at p < 0.05.
RESULTS: Among 2565 patients, 93 (3.6%) presented with bone only metastasis (BOM) and 135 (5.3%) presented with bone and visceral metastasis together. The median age was 51 years, with females predominating. Multivariate analysis revealed that triple-negative breast carcinoma had lower odds (OR 0.36, 95% CI (0.16-0.79) p < 0.001). Advanced T and N stages and tumor grade II were linked to higher odds of bone-only metastasis. The 2-year overall survival of participants with BOM was 93% (CI: 83.7-97%).
CONCLUSION: This study identifies key risk factors that provide the basis for early detection and intervention strategies. While it has a few limitations, these findings can guide future research and inform risk assessment models for more diverse populations.